SB 1059 would require employers to provide paid leave for employees experiencing a pregnancy loss, such as miscarriage or stillbirth, or related medical reasons. This bill would directly affect workers in the state who have a pregnancy loss by allowing them to take time off work with pay for this specific health event. The key provision establishes a new paid leave entitlement separate from existing family or medical leave policies. The bill was referred to the Labor & Industry committee on October 16, 2025, for further review.
SB 680 amends the existing Fair Contracting for Health Care Practitioners Act by expanding its definition of "health care practitioner." This bill specifically adds speech-language pathologists, occupational therapists, physical therapists, and respiratory therapists to the list of professionals covered by the act. The original act prohibits the enforcement of certain noncompete agreements for health care practitioners. Therefore, these newly included professionals would also fall under the protections against such noncompete covenants.
SB 507 amends Pennsylvania's medical licensing law to reestablish the State Board of Medical Education and Licensure as the State Board of Medicine and update its structure. It directly affects midwifery professionals by creating three new license categories: midwifery, nurse-midwife, and certified midwife. The bill establishes specific requirements and definitions for these licenses under the board's authority. This change clarifies licensing pathways for midwifery practitioners within the state's medical regulatory framework. The bill passed final passage on October 21, 2025.
HB 1853 amends Pennsylvania's licensing law for social workers, marriage and family therapists, and professional counselors. It updates definitions, licensing procedures, and board powers while adding a specific restriction: it prohibits the use of the title "Licensed Recreational Therapist" for professionals not meeting the defined standards for these licensed roles. The bill directly affects current license holders and applicants in these specific mental health professions within Pennsylvania. Key provisions include clarifying board functions, licensing requirements, out-of-state license endorsement rules, and adding penalties for unauthorized title use.
SB 648 establishes new requirements for hospital-based financial assistance programs for residents of Pennsylvania. It mandates the Department of Health to create uniform application forms, a one-page summary template for hospital eligibility policies, and a brief statement about financial assistance availability. Hospitals must post these forms and their full financial assistance policies online, provide the summary to patients upon intake and discharge, and include the brief statement on all billing and admission paperwork. Additionally, patients are not responsible for bills while their application is under review, and hospitals must submit their policies to the Department of Health for public display.
HB 111 prohibits life insurance companies in Pennsylvania from denying coverage, limiting benefits, or charging higher rates to applicants or policyholders solely because they have been prescribed an opioid overdose reversal agent (like naloxone). The bill directly affects individuals who use these medications, including those with opioid use disorder or at risk of overdose. It defines "adverse action" to include these discriminatory practices and makes such actions violations of existing laws against unfair insurance practices. The law takes effect 60 days after enactment.
Senate Bill 716 amends Pennsylvania's Mental Health Procedures Act, primarily to update terminology and expand the scope of mental health services. The bill explicitly includes "substance use disorder" as a mental illness, making it eligible for treatment under the act. It also clarifies that assisted outpatient treatment services can encompass substance use disorder treatments, especially when co-occurring with a primary mental illness diagnosis. Additionally, the bill updates outdated language for conditions such as intellectual disability, alcohol use disorder, and age-related cognitive decline.
HB 1365 establishes Pennsylvania's Medication-Induced Movement Disorders Screening Education Program within the Department of Health. The program requires the development of educational materials for healthcare providers and the public about symptoms and screening for involuntary movement disorders caused by long-term mental health medications. It mandates the Department of Health to create electronic resources posted online and distribute guidance to facilities serving high-risk populations, including coordination with agencies like Mental Health Services and the Department of Aging. The bill focuses on raising awareness and standardizing screening practices, with implementation required within 60 days of enactment.
HB 1527 updates the existing Rare Disease Advisory Council established in 2017, clarifying its structure and responsibilities. The bill directly affects patients with rare diseases and requires coordination among the Department of Health, Insurance Department, Department of Human Services, and Department of Education. Key provisions mandate the council to advise state agencies on rare disease research, treatment access, insurance coverage, and resource allocation. It also specifies how departments must collaborate on policies impacting rare disease patients, ensuring a unified state approach.
HB 922 requires health insurance plans in Pennsylvania to cover fertility preservation services, such as freezing eggs, sperm, or embryos, without cost-sharing (like deductibles or copays). This applies to individuals under 45 at risk of infertility due to medical treatments (e.g., cancer therapy), including covered spouses and dependents. The bill mandates coverage for specific services like storage, consultations, embryo transfers, and related diagnostics, while prohibiting preexisting condition exclusions or arbitrary limits on coverage. It also requires storage coverage for five years (or until age 18 for minors) and aligns with medical guidelines from the American Society for Reproductive Medicine.
